FutureTechMedia

Amyotrophic Lateral Sclerosis (ALS) Market Insights, Epidemiology and Forecast 2023 (Etiology, Path Physiology, Symptoms, Diagnosis, Drugs)

Press Release   •   Nov 07, 2016 02:51 EST

The Report “Amyotrophic lateral sclerosis (ALS) - Market Insights, Epidemiology and Market Forecast-2023" Reports provides an overview of the disease and global market trends of the Crohn's disease for the seven major markets ie: United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Amyotrophic lateral sclerosis (ALS) forecasted market share for ten years to 2023 segmented by seven major markets. In addition, the report also includes global forecast of epidemiology of Amyotrophic lateral sclerosis (ALS) till 2023.

Key Companies covered in this report are Covis Pharmaceutical Inc., Eisai Co. Ltd., GlaxoSmithKline plc, Mitsubishi Tanabe Pharma Corp., Eisai Co. Ltd., Evotec AG, F. Hoffmann-La Roche Ltd., Genentech Inc., UCB S.A., UniQure N.V., Valeant Pharmaceuticals International Inc., ViroMed Co. Ltd. etc.

Get SAMPLE of Report Spread across 100 pages with 20 Figures Now available at http://www.rnrmarketresearch.com/contacts/request-sample?rname=676923

Scope

  • Report covers the disease overview including etiology, path physiology, symptoms, diagnosis, disease management, and current treatment options.
  • Marketed information including available prescription drugs, its patent and exclusivity details followed by drug sales till 2018.
  • The Report also covers the detailed global historical and forecasted epidemiological data covering United States, EU5, Japan and rest of the word from 2013-2023.
  • It also provides Amyotrophic lateral sclerosis (ALS) for United States, EU5 and Japan from 2013 and forecasted Market to 2023.

Key Coverage and Benefits

  • The report will help in developing business strategies by understanding the trends shaping and driving the global Amyotrophic lateral sclerosis (ALS) market.
  • Identifying patient populations in the global "Amyotrophic lateral sclerosis (ALS)market to improve product design, pricing, and launch plans.
  • Organize sales and marketing efforts by identifying the best opportunities for Amyotrophic lateral sclerosis (ALS) therapeutics in each of the markets covered.
  • To understand the future market competition in the global Amyotrophic lateral sclerosis (ALS) therapeutics market and Insightful review of the key market drivers and barriers.

List of Tables

Table 1: Drug Description

Table 2: Drug, Marketed Details United States (US)

Table 3: Drug, Patent Number Specific Patent Expiry in US (Year), 2015

Table 4: Drug, Patent Details for US

Table 5: Amyotrophic lateral sclerosis (ALS) Drug Sales (USD Millions)-2023

Table 6: Global Epidemiology of Amyotrophic lateral sclerosis (ALS) (2013-2023)

Table 7: Amyotrophic lateral sclerosis (ALS) Global Market (USD Millions), (2013-2015)

Table 8: Amyotrophic lateral sclerosis (ALS) Global Market (USD Millions), (2016-2023)

Table 9: Amyotrophic lateral sclerosis (ALS) US Market (USD Millions), (2013-2015)

Table 10: Amyotrophic lateral sclerosis (ALS) US Market (USD Millions), (2016-2023)

Table 11: Amyotrophic lateral sclerosis (ALS) Germany Market (USD Millions), (2013-2015)

Table 12: Amyotrophic lateral sclerosis (ALS) Germany Market (USD Millions), (2016-2023)

Table 13: Amyotrophic lateral sclerosis (ALS) United Kingdom Market (USD Millions), (2013-2015)

Table 14: Amyotrophic lateral sclerosis (ALS) United Kingdom Market (USD Millions), (2016-2023)

Table 15: Amyotrophic lateral sclerosis (ALS) France Market (USD Millions), (2013-2015)

Table 16: Amyotrophic lateral sclerosis (ALS) France Market (USD Millions), (2016-2023)

Table 17: Amyotrophic lateral sclerosis (ALS) Italy Market (USD Millions), (2013-2015)

Table 18: Amyotrophic lateral sclerosis (ALS) Italy Market (USD Millions), (2016-2023)

Table 19: Amyotrophic lateral sclerosis (ALS) Spain Market (USD Millions), (2013-2015)

Table 20: Amyotrophic lateral sclerosis (ALS) Spain Market (USD Millions), (2016-2023)

Table 21: Amyotrophic lateral sclerosis (ALS) Japan Market (USD Millions), (2013-2015)

Table 22: Amyotrophic lateral sclerosis (ALS) Japan Market (USD Millions), (2016-2023)

Table 23: Amyotrophic lateral sclerosis (ALS) ROW Market (USD Millions), (2013-2015)

Table 24: Amyotrophic lateral sclerosis (ALS) ROW Market (USD Millions), (2016-2023)

List of Figures

Figure 1: Amyotrophic lateral sclerosis (ALS) Drug Sales (USD Millions)-2023

Figure 2: Global Epidemiology of Amyotrophic lateral sclerosis (ALS) (2013-2023)

Figure 3: Amyotrophic lateral sclerosis (ALS) Global Market (USD Millions), (2013-2015)

Figure 4: Amyotrophic lateral sclerosis (ALS) Global Market (USD Millions), (2016-2023)

Figure 5: Amyotrophic lateral sclerosis (ALS) US Market (USD Millions), (2013-2015)

Figure 6: Amyotrophic lateral sclerosis (ALS) US Market (USD Millions), (2016-2023)

Figure 7: Amyotrophic lateral sclerosis (ALS) Germany Market (USD Millions), (2013-2015)

Figure 8: Amyotrophic lateral sclerosis (ALS) Germany Market (USD Millions), (2016-2023)

Figure 9: Amyotrophic lateral sclerosis (ALS) United Kingdom Market (USD Millions), (2013-2015)

Figure 10: Amyotrophic lateral sclerosis (ALS) United Kingdom Market (USD Millions), (2016-2023)

Figure 11: Amyotrophic lateral sclerosis (ALS) France Market (USD Millions), (2013-2015)

Figure 12: Amyotrophic lateral sclerosis (ALS) France Market (USD Millions), (2016-2023)

Figure 13: Amyotrophic lateral sclerosis (ALS) Italy Market (USD Millions), (2013-2015)

Figure 14: Amyotrophic lateral sclerosis (ALS) Italy Market (USD Millions), (2016-2023)

Figure 15: Amyotrophic lateral sclerosis (ALS) Spain Market (USD Millions), (2013-2015)

Figure 16: Amyotrophic lateral sclerosis (ALS) Spain Market (USD Millions), (2016-2023)

Figure 17: Amyotrophic lateral sclerosis (ALS) Japan Market (USD Millions), (2013-2015)

Figure 18: Amyotrophic lateral sclerosis (ALS) Japan Market (USD Millions), (2015-2023)

Figure 19: Amyotrophic lateral sclerosis (ALS) ROW Market (USD Millions), (2013-2015)

Figure 20: Amyotrophic lateral sclerosis (ALS) ROW Market (USD Millions), (2016-2023)

Order a Copy of This Report http://www.rnrmarketresearch.com/contacts/purchase?rname=676923

About Us:
RnRMarketResearch.com is your single source for all market research needs. Our database includes 100,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.

Contact Us:
We provide 24/7 online and offline support to our customers. Contact us for your special interest needs and we will get in touch within 24hrs to help you find the market research report you need.
sales@rnrmarketresearch.com

+ 1 888 391 5441